Get all your news in one place.
100's of premium titles.
One app.
Start reading
MarketBeat
MarketBeat
Gabriel Osorio-Mazilli

2 Healthcare Stocks to Watch as JPMorgan Boosts Gilead Rating

When Wall Street analysts decide to come out of their caves and boost a certain stock, retail investors should pay attention to the motives behind the decision as it can signal a shift in sentiment toward an entire sector.

That’s exactly what happened when J.P. Morgan recently upgraded Gilead Sciences Inc. (NASDAQ: GILD), highlighting renewed confidence in the healthcare space.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.